Junji Kanazawa

Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration

Takeshi Takahashi, Junji Kanazawa, Shiro Akinaga et al. · Cancer Chemotherapy and Pharmacology · 1999 · 36 citations

Tumor Biology, Medicinal Chemistry, Antitumor Activity +12

The relationship between the antitumor activity and the ribonucleotide reductase inhibitory activity of (E )-2?? -deoxy-2?? -(fluoromethylene) cytidine, MDL 101,731

Junji Kanazawa, Takeshi Takahashi, Shiro Akinaga et al. · Anti-Cancer Drugs · 1998 · 29 citations

Antitumor Activity, Aldo-keto Reductase, Cancer Biology +20

Metabolism and ribonucleotide reductase inhibition of ( E   )-2′-deoxy-2′-(fluoromethylene)cytidine, MDL 101,731, in human cervical carcinoma HeLa S 3 cells

Takeshi Takahashi, Akiko Nakashima, Junji Kanazawa et al. · Cancer Chemotherapy and Pharmacology · 1998 · 23 citations

Mdl 101,731, Oncology, Cervical Cancer +8

Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis

Junji Kanazawa, So Ohta, Kenya Shitara et al. · Cancer Immunology Immunotherapy · 2000 · 14 citations · Full text

Antibody Km871, Cancer Immunosurveillance, Medicine +10

Effect of 5‐fluorouracil and epidermal growth factor on cell growth and dihydropyrimidine dehydrogenase regulation in human uterine cervical carcinoma SKG‐IIIb cells

Naomi Kashima, Masatsugu Ueda, Junji Kanazawa · Cancer Science · 2003 · 13 citations · Full text